Granules Current Share Price | Granules Stock Screener
GRANULES
Pharmaceuticals
Granules Current Stock Price Today
Live Share Price NSE
₹875.50
▲
5.10 (0.59%)
Live Share Price BSE
₹875.00
▲
4.95 (0.57%)
As of September 18, 2026, the live Granules share price (NSE: GRANULES) is ₹875.50 on NSE and ₹875.00 on BSE, up 0.59% from the previous close, with shares trading between ₹865.90 and ₹890.40 in today's trading session, and a 52-week range of ₹515.00–₹909.30.
Browse GRANULES annual financials to support your investment research.
Use the Granules stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Granules Market Cap
₹22,532.17 Cr.
GRANULES P/E Ratio (TTM)
33.73
Granules P/B Ratio
4.73
EPS (TTM)
₹24.47
Dividend Yield
0.19%
Debt to Equity
0.34
GRANULES 52 Week High
₹909.30
Granules 52 Week Low
₹515.00
Operating Margin
23.00%
Profit Margin
13.63%
GRANULES Revenue (TTM)
₹1,482.00
EBITDA
₹364.00
Net Income
₹202.00
Total Assets
₹7,720.00
Total Equity
₹5,085.00
Granules Current Share Price Chart
Track the current Granules share price and stock price with an interactive chart. Analyse GRANULES price trends, trading volume, historical performance, and volatility across different timeframes — the complete Granules stock quote in one place.
Granules Company Profile - Fundamental Screener
Screen Granules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GRANULES shares.
Granules India Limited is a vertically integrated pharmaceutical company founded in 1991. It manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company specializes in off-patent drugs and first-line defense products like Paracetamol, Ibuprofen, Metformin, and Guaifenesin. Granules India operates seven manufacturing facilities, six in...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
C Krishna Prasad
ISIN
INE101D01020
Website
https://www.granulesindia.com
Granules Balance Sheet Screener
Screen GRANULES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 7,720 | 6,253 | 5,521 | 4,905 | 4,513 | 3,714 | 3,228 | 2,983 | 2,677 | 1,879 |
| Current Assets | 3,768 | 3,116 | 2,905 | 2,574 | 2,505 | 1,997 | 1,629 | 1,282 | 1,187 | 828 |
| Fixed Assets | 3,250 | 2,427 | 2,096 | 1,911 | 1,541 | 1,332 | 1,204 | 944 | 777 | 644 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 543 | 534 | 213 | 256 | 284 | 367 | 491 | 557 | 495 | 188 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5,085 | 3,716 | 3,226 | 2,835 | 2,587 | 2,173 | 1,844 | 1,530 | 1,304 | 904 |
| Share Capital | 25 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 23 |
| Reserves & Surplus | 4,695 | 3,691 | 3,201 | 2,811 | 2,562 | 2,149 | 1,818 | 1,504 | 1,279 | 881 |
Granules Income Statement Screener - Profit & Revenue Analysis
Screen Granules income statement and profit fundamentals.
Analyze GRANULES quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Granules share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,482 | 1,467 | 1,230 | 1,225 | 1,294 | 1,374 | 1,171 | 1,171 | 960 | 1,139 | 1,199 | 984 | 1,190 | 1,150 | 1,034 |
| Expenses | 1,119 | 1,138 | 945 | 989 | 1,019 | 1,080 | 920 | 921 | 763 | 907 | 967 | 849 | 977 | 905 | 837 |
| EBITDA | 364 | 329 | 284 | 236 | 275 | 295 | 251 | 251 | 197 | 232 | 232 | 135 | 213 | 245 | 197 |
| Operating Profit % | 23.00% | 22.00% | 21.00% | 18.00% | 21.00% | 22.00% | 21.00% | 21.00% | 20.00% | 20.00% | 19.00% | 14.00% | 18.00% | 21.00% | 19.00% |
| Depreciation | 82 | 80 | 64 | 69 | 72 | 74 | 53 | 53 | 53 | 57 | 49 | 49 | 53 | 52 | 40 |
| Interest | 33 | 21 | 24 | 24 | 29 | 29 | 29 | 27 | 26 | 27 | 19 | 23 | 26 | 29 | 6 |
| Profit Before Tax | 262 | 240 | 198 | 145 | 176 | 202 | 176 | 181 | 128 | 153 | 164 | 66 | 136 | 170 | 150 |
| Tax | 61 | 60 | 46 | 32 | 45 | 52 | 46 | 47 | 31 | 35 | 44 | 18 | 34 | 45 | 39 |
| Net Profit | 202 | 180 | 152 | 113 | 131 | 150 | 130 | 135 | 97 | 118 | 120 | 48 | 102 | 126 | 111 |
| EPS | 8.23 | 7.26 | 6.27 | 4.64 | 5.38 | 6.19 | 5.35 | 5.56 | 4.01 | 4.85 | 4.94 | 1.98 | 4.22 | 5.18 | 4.48 |
Granules Cash Flow Screener - Liquidity Fundamentals
Screen GRANULES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 793 | 867 | 439 | 739 | 332 | 433 | 476 | 262 | -1 | 188 |
| Investing Activities | -758 | -689 | -358 | -192 | -379 | -277 | -160 | -270 | -462 | -326 |
| Financing Activities | 379 | -93 | 8 | -440 | 190 | -299 | -213 | -17 | 529 | 56 |
| Net Cash Flow | 414 | 85 | 90 | 107 | 143 | -144 | 103 | -25 | 66 | -82 |
Granules Shareholding Pattern Screener
See Granules shareholding pattern with promoter, FII, and DII holdings.
Check Granules promoter holding and ownership changes for GRANULES on TickJournal.
| Item | 2026-Feb | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 38.02% | 38.02% | 38.02% | 38.84% | 38.82% | 38.82% | 38.82% | 41.96% |
| FII Holding | 13.79% | 15.31% | 17.50% | 15.15% | 0.00% | 14.09% | 13.55% | 19.57% |
| DII Holding | 18.51% | 17.01% | 16.11% | 22.45% | 22.74% | 17.92% | 17.48% | 10.70% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.31% | 19.09% | 17.85% | 16.07% | 16.54% | 18.28% | 19.19% | 19.38% |
| Other Holding | 10.38% | 10.58% | 10.53% | 7.50% | 21.89% | 10.89% | 10.96% | 8.39% |
| Shareholder Count | 163,818 | 160,286 | 169,422 | 169,802 | 169,700 | 165,542 | 163,184 | 182,142 |
Granules Share Dividend Screener - Share Yield Analysis
Check Granules dividend history with payout and yield data.
View Granules dividend details including ex-dates and amounts for GRANULES stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.75 | 0.19% |
| 2025-March | ₹1.50 | 0.24% |
| 2024-March | ₹1.50 | 0.31% |
| 2023-March | ₹1.50 | 0.35% |
| 2022-March | ₹1.50 | 0.52% |
| 2021-March | ₹1.50 | 0.49% |
| 2020-March | ₹1.00 | 0.33% |
| 2019-March | ₹1.00 | 0.70% |
| 2018-March | ₹1.00 | 0.87% |
| 2017-March | ₹0.90 | 0.87% |
Granules Stock Index Membership
See which indices include Granules stock.
Check GRANULES index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY HEALTHCARE
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Granules Market Events Screener - Corporate Actions
Get Granules corporate actions including splits, bonuses, and buybacks.
Check Granules stock events that may affect GRANULES share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-06 | 2026-08-06 | Annual General Meeting | NA | 19.76% |
| 2026-07-30 | 2026-07-30 | Dividend | ₹ 1.75 /share | 19.40% |
| 2026-07-21 | 2026-07-21 | Quarterly Result Announcement | NA | 2.10% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 8.03% |
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -6.49% |
| 2026-01-22 | 2026-01-22 | Extraordinary General Meeting | NA | -10.66% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.09% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.97% |
| 2025-08-07 | 2025-08-07 | Annual General Meeting | NA | -16.92% |
| 2025-07-31 | 2025-07-31 | Dividend | ₹ 1.50 /share | -6.98% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 18.01% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -2.83% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -9.57% |
| 2024-08-06 | 2024-08-06 | Annual General Meeting | NA | 60.49% |
| 2024-07-30 | 2024-07-30 | Dividend | ₹ 1.50 /share | 41.30% |
Granules Competitors Screener - Peer Comparison
Screen GRANULES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Granules Company Announcements - News Screener
Screen GRANULES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-17 | Update | - |
| 2026-09-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-06 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-27 | Transcript Of The Earnings Call For Q1 Of FY27 | - |
| 2026-07-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-21 | Board Meeting Outcome for Outcome Of The Board Meeting Dated July 21 2026 | - |
| 2026-07-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-15 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-15 | Reg. 34 (1) Annual Report. | - |
| 2026-07-15 | Notice Of Annual General Meeting Along With Integrated Annual Report For FY26 | - |
| 2026-07-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-09 | Board Meeting Intimation for Inter-Alia To Consider And Approve The Unaudited Financial Results For The First Quarter Ended On June 30 2026. | - |
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |